| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |